Thomas Bollyky describes the crisis emerging over access to treatment for diabetes, cancers, and other non-communicable diseases (NCDs). Bollyky argues that this crisis could transform the global response to NCDs as the last treatment access crisis transformed the international approach to HIV/AIDS.

Thomas Bollyky discusses the brewing fight over intellectual property and access to noncommunicable disease medicines in low- and middle-income countries and a potential way forward.

CFR Senior Fellow Thomas Bollyky argues that new strategies are needed to address the latest treatment-access crisis over patented medications, particularly as noncommunicable diseases continue to rapidly emerge in low- and middle-income countries.

A comprehensive new study of the world's health status has the potential to dramatically improve how developing countries address surging problems like noncommunicable diseases, writes CFR's Thomas Bollyky.

Christopher J.L. Murray and Jennifer Kates discuss disease from the perspective of shaping U.S. policy, spending priorities, and potential action.

Kelly Brownell, director of the Rudd Center for Food Policy and Obesity at Yale University, and Derek Yach, senior vice president of the Vitality Group and member of PepsiCo's Scientific Advisory Board, debate the role of the food and beverage industry in the global fight on obesity.

In this Council on Foreign Relations meeting, "Is There a Seat at the Table for the Food and Beverage Industry in the Global Fight Against Obesity," Drs. Kelly Brownell, Director, Rudd Center for Food Policy and Obesity, Yale University, and Derek Yach, Senior Vice President, Vitality Group, and Member, PepsiCo Scientific Advisory Board, debate the involvement of the food and beverage industry in the fight against global obesity.

Thomas Bollyky, CFR's senior fellow for global health, economics, and development, leads a discussion on the rise of noncommunicable diseases in the developing world, attitudes towards them, and solutions for addressing them.

CFR Senior Fellow Thomas J. Bollyky discusses the rise of noncommunicable diseases in low- and middle-income countries, the United Nations' efforts to address this rapidly emerging health problem, and paths for collective action.

One year after the UN's high-level meeting on noncommunicable diseases, little progress has been made in generating momentum and new resources. But with the right focus and strategies, there is room to move forward, says CFR's Thomas Bollyky.

James Habyarimana, Matthew L. Myers, and Bernhard Weigl discuss scalable and practical strategies developing countries can use to address the global health challenges of noncommunicable diseases. This session is part two of the two session meeting, Noncommunicable Diseases and the New Global Health.

Experts discuss scalable and practical strategies developing countries can use to address the global health challenges of noncommunicable diseases.

This session is part two of the two session meeting, Noncommunicable Diseases and the New Global Health.

Experts discuss scalable and practical strategies developing countries can use to address the global health challenges of noncommunicable diseases.

This session is part two of the two session meeting, Noncommunicable Diseases and the New Global Health.

Thomas R. Frieden, director of U.S. Centers for Disease Control and Prevention and administrator of the Agency for Toxic Substances and Disease Registry, discusses the challenges facing low- and middle-income countries in combating noncommunicable diseases.

This session is part one of the two session meeting, Noncommunicable Diseases and the New Global Health.

Dr. Thomas R. Frieden, Director, U.S. Centers for Disease Control and Prevention discusses the new set of global health challenges arising in low- and middle-income countries and the scalable, practical strategies that can help address them.

The main health threat in developing states today is not plagues or parasites but illnesses such as cancer and diabetes, noncommunicable diseases long associated with the rich world.

As tobacco use proliferates in the developing world, an innovative incentive mechanism could supplement tobacco control efforts in low- and middle-income countries.

The 2011 high-level UN meeting on non-communicable diseases fell far short of the major funding and targets agreed to at a similar meeting on HIV/AIDS a decade ago, which CFR's Thomas Bollyky says indicates a need for different actors and approaches on chronic diseases.

Why is the UN convening a summit-level meeting on illnesses like cancer and diabetes? This CFR guide looks at how these non-communicable diseases have amplified the burdens on developing states and the global threat they pose.

NCDs such as cancer and heart disease are becoming leading causes of death in the developing world and will be the focus of a September UN meeting. But health experts and others are divided about how much funding should go into a global campaign aimed at preventing NCDs and whether infectious disease programs will suffer as a result.